A conversation with Marc Buyse, founder of CluePoints on risk based monitoring in clinical trials
A conversation with Marc Buyse, founder of CluePoints on risk based monitoring in clinical trials
This video is part of a series of conversations on risk-based monitoring. Click here to see all the videos.
For more videos of Marc Buyse, see also:
‘Hypothesis-Free’: Getting Proactive About Signal Detection
December 5th 2023Elizabeth Smalley, director of product management, data, and analytics at ArisGlobal speaks about her work at the software company in supporting the efforts of life sciences clinical and pharmacovigilance teams in signal detection.